Eylea – Macular Degeneration Treatment
Eylea is an FDA-approved treatment for the Neovascular (Wet) Age-Related Macular Degeneration (AMD). AMD is a slowly progressing condition where new blood vessels grow on the macula, which is the central part of the retina. These new blood vessels are weak and often leak blood, causing damage to the light-sensitive tissue of the macula. As a result, a patient’s vision gradually deteriorates, which might lead to complete vision loss. AMD mostly affects older people, and it is the leading cause of blindness for people over 65.
While Eylea cannot cure AMD, it can slow or stop the growth of the abnormal blood vessels that damage the retinal tissue. In this way, Eylea can halt the process of vision loss. In order to preserve as much vision as possible, it is very important to detect AMD and start Eylea therapy early. Our experienced doctors can diagnose AMD even before the patient notices any vision loss. They use advanced Optical Coherence Tomography (OCT) equipment, fluorescein angiograms and fundus photos of the retina for this purpose.
Visit our contact page to schedule a consultation with one of our experienced eye doctors who can perform a complete evaluation of your eye health, diagnose any vision problems and prescribe the most appropriate treatment.
Studies have shown that the best vision preservation results are achieved when the Eyela therapy is started in an early stage of AMD. This is why it is important to consult with one of our experienced doctors as soon as you suspect that you might have a vision problem. Our doctors are skilled in early detection of AMD and administration of this convenient, effective AMD treatment.
The specialists at Eye Health Partners & VisionAmerica are dedicated to providing the latest technologies, including Eylea, Lucentis, and Avastin to treat patients with macular degeneration. They also provide treatments for other retinal diseases such as diabetic retinopathy. To schedule a consultation, visit our Contact Us page to schedule a consultation with one of our Albertville, Birmingham, Columbia, Cullman, Gadsden, Murfreesboro, Nashville, or Oxford-Anniston retina specialists.